email   Email Us: info@lupinepublishers.com phone   Call Us: +1 (914) 407-6109   57 West 57th Street, 3rd floor, New York - NY 10019, USA

Lupine Publishers Group

Lupine Publishers

  Submit Manuscript

ISSN: 2637-6660

Archives of Nanomedicine: Open Access Journal

Mini Review(ISSN: 2637-6660)

Nanotechnology in Cancer: an Overview on Importance of Patient’s Screening in Nanomedicine Based Combinational Therapies

Volume 1 - Issue 3

Subodh Kumar, Phulen Sarma, Rahul Soloman Singh, Dibbanti Harikrishna Reddy, Sukhjinder Singh, Ashutosh Singh and Bikash Medhi*

  • Author Information Open or Close
    • Department of Pharmacology, PGIMER, India

    *Corresponding author: Bikash Medhi, Department of Pharmacology, PGIMER, Chandigarh, India, 160012

Received: May 12, 2018;   Published: May 29, 2018

DOI: 10.32474/ANOAJ.2018.01.000112

Full Text PDF

To view the Full Article   Peer-reviewed Article PDF

Abstract

Targeting cancer using nanomedicine is not a new concept. Earlier focus was on targeted therapy and then concept came of combinational therapy. Along with the use of combinational therapies, Pre-selection screening of the patients using molecular approach is equally important to achieve the maximum benefit to the cancer patients.

Keywords: Nanotechnology; Nanomedicine; Cancer; Combinational Therapy; Biological Systems; Liposomal Formulations; Targeting Tumors; Cardiomyopathy; Solid Tumors; Meta-Analysis

Abstract| Mini Review| Nanotechnology and Nanomedicine| Conclusion| References|

https://www.high-endrolex.com/21